ANI Pharmaceuticals | ANIP - Eps Gewinn Pro Aktie

Aktienkurs
74.67
Täglich Wechseln
-0.15 -0.20%
Monatlich
-0.57%
Jährlich
16.20%
Q1 Prognose
72.43

Fiscal Kalender Aktuell Konsens Zuletzt Datum
FY2026Q1 Mar/2026 1.58 1.70 May/08 2026
FY2025Q4 Dec/2025 2.33 1.97 1.63 Feb/27 2026
FY2025Q3 Sep/2025 2.04 1.71 1.34 Nov/07 2025
FY2025Q2 Jun/2025 1.80 1.43 1.02 Aug/08 2025
FY2025Q1 Mar/2025 1.70 1.12 1.21 May/09 2025




Eps Veränderung Datum
AbbVie USD 2.71 0.85 2025-12
ANI Pharmaceuticals USD 2.33 0.29 2025-12
Assertio Holdings USD -0.03 0.01 2024-09
Aurora Cannabis CAD -0.64 0.36 2025-12
Canopy Growth CAD -0.05 0.03 2025-12
Eli Lilly USD 7.54 0.52 2025-12
Emergent BioSolutions USD -0.77 0.29 2023-12
Heron Therapeutics USD -0.02 0.02 2025-12
Hikma Pharmaceutical USD 0.65 0.12 2025-12
Knight Therapeutics CAD -0.09 0.12 2025-12
Nektar Therapeutics USD -0.18 0.07 2024-09
Novartis USD 1.54 0.48 2025-12
Omeros USD -1.12 0.37 2024-06
Perrigo USD 0.77 0.03 2025-12
Sun Pharmaceuticals INR 12.8 0.2 2025-12
Teva Pharmaceutical Industries USD 2.98 0.43 2025-12